首页> 美国卫生研究院文献>Frontiers in Bioengineering and Biotechnology >Patents as Early Indicators of Technology and Investment Trends: Analyzing the Microbiome Space as a Case Study
【2h】

Patents as Early Indicators of Technology and Investment Trends: Analyzing the Microbiome Space as a Case Study

机译:专利是技术和投资趋势的早期指标:以微生物组空间为案例分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The human microbiome is the collective of microbes living in symbiosis on and within humans. Modulating its composition and function has become an attractive means for the prevention and treatment of a variety of diseases including cancer. Since the initiation of the human microbiome project in 2007, the number of academic publications and active patent families around the microbiome has grown exponentially. Screening patent databases can be useful for the early detection and the tracking of new technology trends. However, it is not sufficient to assess portfolio sizes because emerging players with small but high-quality patent portfolios will be missed within the noise of large but low-quality portfolio owners. Here we used the consolidated database and software tool PatentSight to benchmark patent portfolios, and to analyze key patent owners and innovators in the microbiome space. Our study shows how in-depth patent analyses combining qualitative and quantitative parameters can identify actionable early indicators of technology and investment trends from large patent datasets.
机译:人类微生物组是生活在人类内部和内部共生的微生物的集合。调节其组成和功能已成为预防和治疗包括癌症在内的多种疾病的有吸引力的手段。自2007年启动人类微生物组计划以来,围绕微生物组的学术出版物和活跃的专利家族数量呈指数增长。筛选专利数据库对于早期发现和跟踪新技术趋势可能很有用。但是,仅仅评估投资组合的规模还不够,因为拥有大型但质量低劣的投资组合所有者的噪音会错过那些规模较小但质量高的专利组合的新兴参与者。在这里,我们使用了整合的数据库和软件工具PatentSight来对专利组合进行基准测试,并分析微生物组领域的关键专利所有者和创新者。我们的研究表明,结合定性和定量参数进行深入的专利分析如何从大型专利数据集中识别可行的早期技术指标和投资趋势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号